Most Recent
Zoetis loses appeal over pig vaccine patents
Intellectual Property 2024-11-20 11:16 pm By Sam Matthews

US animal drug manufacturer Zoetis has lost its challenge a ruling that chucked out three of its patents for a single-dose vaccine to protect pigs from enzootic pneumonia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Eli Lilly loses bid for ‘>Hair’ trade mark
Intellectual Property 2024-10-03 2:51 pm By Andy Sidler

US drug giant Eli Lilly cannot register a trade mark consisting of the word ‘hair’ preceded by the ‘greater-than’ symbol, despite winning registration in the UK, Switzerland and New Zealand.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Aldi blasts ‘desperate’ copycat case over Little Bellies fruit snacks
Intellectual Property 2024-06-27 11:25 pm By Sam Matthews

Aldi has slammed what it says is a novel copyright infringement case alleging the German grocery chain copied the “vibe” of a rival’s snack packaging. 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Otsuka defends validity of injectable Abilify patent, accuses Sun Pharma of infringement
Intellectual Property 2024-05-30 2:19 pm By Sam Matthews

Otsuka Pharmaceutical has hit back at suit filed by Indian generics company Sun Pharma seeking to invalidate its patent for blockbuster antipsychotic Abilify, filing a cross-claim seeking to restrain Sun Pharma from infringing the patent with a generic version of the drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

McDonald’s resists giving sales data to Hungry Jack’s board, CEO in row over misleading ads
Intellectual Property 2024-05-23 11:48 pm By Christine Caulfield

In a continuing fight over damages stemming from misleading burger ads, McDonald’s has opposed production of sales information to Hungry Jack’s directors and its top executive, saying the information was confidential and the companies “fierce competitors”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

IPH moves to swallow up IP services rival QANTM with $265M offer
Corporate 2024-05-08 11:04 pm By Cat Fredenburgh

IP services giant IPH Limited, which owns IP boutiques Spruson & Ferguson and Griffith Hack, has made an offer worth $265 million to acquire its rival QANTM Limited, after failing to woo its main competitor with a takeover bid in 2018.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Personal injury firm succeeds in trade mark stoush against rival
Intellectual Property 2024-05-08 11:26 pm By Andy Sidler

Melbourne personal injury firm Law Partners Compensation Lawyers has successfully opposed a small Queensland firm’s registration of the name ‘Australian Law Partners’, with IP Australia saying ALP’s claim to distinctiveness was “not compelling.” 

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Hungry Jack’s wants 5 years of Big Mac sales data in spat over damages for misleading ads
Intellectual Property 2024-03-27 12:33 pm By Sam Matthews

Hungry Jack’s is seeking five years of Big Mac sales data as it readies for a fight over damages stemming from its claim that its Big Jack burger has 25 per cent more beef than the McDonald’s burger.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Zoetis can appeal Boehringer win over pig vaccine patents
Intellectual Property 2024-03-26 4:25 pm By Christine Caulfield

US animal drug manufacturer Zoetis has been granted leave to appeal a ruling that invalidated three of its patents covering pig vaccines.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sun Pharma challenges Abilify patent term extension
Intellectual Property 2024-03-22 9:01 am By Sam Matthews

Indian generics company Sun Pharma has taken Otsuka Pharmaceutical to court, alleging an extension for the patent for an injectable form of the Japanese drug maker’s blockbuster antipsychotic Abilify was wrongly granted and should be invalidated.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?